Simultaneously, the PI3K–Akt–mTOR signalling pathway is activated, which promotes the secretion of IFN-γ from CD8+ T cells, thereby enhancing the anti-tumour function of T cells [208]. The gene discussed is CD8A; the disease is neoplasm.